摘要
目的:探讨蛋白磷酸酶2A癌性抑制因子在慢性粒细胞白血病各期中的表达及意义。方法:采用免疫化学SP法测定CIP2A在对照组及CML各期中的表达。结果:CIP2A在CML-AP/BP组的表达显著高于对照组和CML-CP组(P<0.05),CML-CP组和对照组比较差异无统计学意义(P>0.05);CIP2A在CML-AP/BP未缓解组明显高于缓解组(P<0.05)。结论:CIP2A在CML-AP/BP骨髓单个核细胞中高表达且与CML发生急变及预后相关。
@@@@Objective:To investigate the expression and significance of cancerous inhibitor of protein phosphatase 2A(CIP2A)in control group and in different phases of CML.Method:The immunohistochemical SP staining was used to detect expression of CIP2A in control group and in different phases of CML.Result:Expression of CIP2A in CML-AP/BP group was significantly higher than that in control group and that in CML-CP group(P<0.05), expression of CIP2A in control group and CML-CP group had no significant difference(P>0.05).CIP2A in no remission group was significantly higher than that in complete remission group(P<0.05).Conclusion:Overexpression of CIP2A in CML bone marrow mononuclear cells plays an important role in CML blast crisis and prognosis.
出处
《中国医学创新》
CAS
2013年第9期122-123,共2页
Medical Innovation of China